Insider · CIK 0002131061
Kartik Krishnan
Files at KTTA (Pasithea Therapeutics Corp.). First filing -, latest -.
In brief
Kartik Krishnan files SEC Form 4 as officer at KTTA (Pasithea Therapeutics Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kartik Krishnan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | KTTA Pasithea Therapeutics Corp. | AGrant or award Stock Option (right to buy)derivative | +1,129,323 | $0.00 | $0 | 1,129,323 | May 5, 2026 |
Questions about Kartik Krishnan
Answered from the filings on this page, as of the latest one.
Is Kartik Krishnan buying or selling?
Kartik Krishnan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kartik Krishnan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kartik Krishnan has 0.
Where does Kartik Krishnan file Form 4?
Kartik Krishnan has filed Form 4 at KTTA (Pasithea Therapeutics Corp.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.